EDGAR·FLOW

Adagio Medical Holdings, Inc. — Form 10-Q

Filed November 16, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 28/100
What the filing says
Adagio Medical's board and shareholders approved a 30-for-1 reverse stock split, effective November 6, 2026 at 5:00 p.m. ET. Each 30 shares of common stock will combine into 1 share; fractional shares will be paid in cash based on the average closing price over the five trading days preceding the amendment filing. No counterparties, dollar amounts, or specific share counts are disclosed in this certificate.
Why this rating

Reverse splits are routine capital structure adjustments, typically signaling low stock price. No financial impact, no business operations change, no financing or strategic deal. Mechanically neutral for shareholders (proportional stake unchanged).

View original filing on SEC.gov ↗ ADGM · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.